{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:59:44Z","timestamp":1762001984518,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ymgmr.2023.101011","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T19:42:10Z","timestamp":1697053330000},"page":"101011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Reduction of lysosome abundance and GAG accumulation after odiparcil treatment in MPS I and MPS VI models"],"prefix":"10.1016","volume":"37","author":[{"given":"Pascale","family":"Tuyaa-Boustugue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Jantzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Broqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille","family":"Tallandier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeni","family":"Entchev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2023.101011_bb0005","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3421","article-title":"The Mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgmr.2023.101011_bb0010","doi-asserted-by":"crossref","DOI":"10.1177\/2326409813517663","article-title":"Lysosomal storage diseases","volume":"2","author":"Alroy","year":"2014","journal-title":"J. Inborn Error. Metabol. Screen."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0015","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl. Sci. Rare Dis."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0020","doi-asserted-by":"crossref","first-page":"v13","DOI":"10.1093\/rheumatology\/ker395","article-title":"Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator","volume":"50","author":"Clarke","year":"2011","journal-title":"Rheumatology."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/diagnostics10030161","article-title":"Mucopolysaccharidosis Type I","volume":"10","author":"Kubaski","year":"2020","journal-title":"Diagnostics (Basel)"},{"year":"2010","series-title":"RMeviuewcopolysaccharidosis VI","author":"Valayannopoulos","key":"10.1016\/j.ymgmr.2023.101011_bb0030"},{"key":"10.1016\/j.ymgmr.2023.101011_bb0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2741\/4490","article-title":"Mucopolysaccharidosis VI pathophysiology diagnosis and treatment","volume":"22","author":"Harmatz","year":"2017","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2018.01.003","article-title":"Clinical presentation and diagnosis of mucopolysaccharidoses","volume":"125","author":"Stapleton","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0045","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","article-title":"Lysosomal disorders: from storage to cellular damage","volume":"1793","author":"Ballabio","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgmr.2023.101011_bb0050","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3390\/ijms21072515","article-title":"Pathogenesis of Mucopolysaccharidoses, an update","volume":"21","author":"Fecarotta","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0055","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the Mucopolysaccharidoses","volume":"81","author":"Simonaro","year":"2001","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-8417-2-4","article-title":"Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI","volume":"2","author":"Tessitore","year":"2009","journal-title":"Pathogenetics."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbrc.2023.04.093","article-title":"Contribution of vesicle trafficking dysregulation to the pathomechanism of mucopolysaccharidosis","volume":"665","author":"Gaffke","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10237-016-0811-4","article-title":"Glycosaminoglycans contribute to extracellular matrix fiber recruitment and arterial wall mechanics","volume":"16","author":"Mattson","year":"2017","journal-title":"Biomech. Model. Mechanobiol."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10719-019-09858-2","article-title":"Compositional and structural analysis of glycosaminoglycans in cell-derived extracellular matrices","volume":"36","author":"Silva","year":"2019","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0080","doi-asserted-by":"crossref","first-page":"a004952","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.sbi.2015.06.004","article-title":"Molecular interactions between chondroitin-dermatan sulfate and growth factors\/receptors\/matrix proteins","volume":"34","author":"Mizumoto","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0090","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.3390\/ijms231911724","article-title":"Pathogenic roles of Heparan sulfate and its use as a biomarker in Mucopolysaccharidoses","volume":"23","author":"Minami","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2014.09.009","article-title":"A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses","volume":"114","author":"Zhang","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2018.04.011","article-title":"Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis","volume":"125","author":"Khan","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/diagnostics10030172","article-title":"Diagnosis of Mucopolysaccharidoses","volume":"10","author":"Kubaski","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ymgmr.2023.101011_bb0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ymgme.2007.03.003","article-title":"Preclinical dose ranging studies for enzyme replacement therapy with idursulfase in a knock-out mouse model of MPS II","volume":"91","author":"Garcia","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/hum.2013.213","article-title":"Similar therapeutic efficacy between a single Administration of Gene Therapy and Multiple Administrations of recombinant enzyme in a mouse model of lysosomal storage disease","volume":"25","author":"Ferla","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/030098589202900203","article-title":"Hepatic storage of Glycosaminoglycans in feline and canine models of Mucopolysaccharidoses I, VI, and VII","volume":"29","author":"Haskins","year":"1992","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14728214.2016.1123690","article-title":"Emerging drugs for the treatment of mucopolysaccharidoses","volume":"21","author":"Giugliani","year":"2016","journal-title":"Expert. Opin. Emerg. Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgmr.2023.101011_bb0130","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pedneo.2022.10.001","article-title":"Current and new therapies for mucopolysaccharidoses","volume":"64","author":"Penon-Portmann","year":"2023","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ymgme.2022.07.014","article-title":"Therapies for lysosomal storage diseases: principles, practice, and prospects for refinements based on evolving science","volume":"137","author":"Grabowski","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233032","article-title":"Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI\u2014evidence from in vitro and in vivo models","volume":"15","author":"Entchev","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2023.101011_bb0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ymgme.2021.07.008","article-title":"MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment","volume":"135","author":"Entchev","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jimd.12467","article-title":"Oral treatment for mucopolysaccharidosis VI: outcomes of the first phase IIa study with odiparcil","volume":"45","author":"Guffon","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1087057113501197","article-title":"A phenotypic compound screening assay for lysosomal storage diseases","volume":"19","author":"Xu","year":"2014","journal-title":"SLAS Discov."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2009.08.002","article-title":"Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation","volume":"99","author":"Wang","year":"2010","journal-title":"Mol. Genet. Metab."},{"author":"Curtain","key":"10.1016\/j.ymgmr.2023.101011_bb0165"},{"key":"10.1016\/j.ymgmr.2023.101011_bb0170","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","article-title":"Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry","volume":"57","author":"Zhang","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-60327-198-1_22","article-title":"Monitoring lysosomal activity in nanoparticle-treated cells","volume":"697","author":"Neun","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0180","doi-asserted-by":"crossref","first-page":"a005199","DOI":"10.1101\/cshperspect.a005199","article-title":"Golgi glycosylation","volume":"3","author":"Stanley","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0185","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1016\/j.bbagen.2013.06.006","article-title":"Biosynthesis and function of chondroitin sulfate","volume":"1830","author":"Mikami","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0190","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/ijms22052766","article-title":"Gene expression-related changes in morphologies of organelles and cellular component Organization in Mucopolysaccharidoses","volume":"22","author":"Gaffke","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/ijms24010477","article-title":"Mucopolysaccharidoses: cellular consequences of Glycosaminoglycans accumulation and potential targets","volume":"24","author":"Leal","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0200","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1538-7836.2006.02064.x","article-title":"A comparison of the \u03b2-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis","volume":"4","author":"Toomey","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0205","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1074\/jbc.M110.192062","article-title":"Secondary storage of dermatan sulfate in Sanfilippo disease","volume":"286","author":"Lamanna","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0210","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2017.12.007","article-title":"Glycosaminoglycan fragments as a measure of disease burden in the mucopolysaccharidosis type I mouse","volume":"123","author":"Saville","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101011_bb0215","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.3390\/ijms22157888","article-title":"Differences in MPS I and MPS II disease manifestations","volume":"22","author":"Hampe","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:40Z","timestamp":1762001680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426923000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":43,"alternative-id":["S2214426923000575"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101011","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of lysosome abundance and GAG accumulation after odiparcil treatment in MPS I and MPS VI models","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101011"}}